Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access


According to recent data, the pathogenetically significant condition for the onset of atopic dermatitis is increasing epidermal permeability barrier and, therefore, a primary step in the treatment and prevention of atopic dermatitis should be control over the skin condition. Effective use of modern methods of prevention of exacerbations helps to reduce the frequency of relapses, lengthen the periods of remissions and, in general, improve the quality of life of sick children.

Restricted Access

P I Gushchin

NRC Institute of Immunology FMBA of Russia

Email: dr.gushchin@yandex.ru
24, Kashirskoe Shosse, Moscow, 115478, Russia

D G Chuvirov

NRC Institute of Immunology FMBA of Russia

24, Kashirskoe Shosse, Moscow, 115478, Russia

  1. Tollefson MM, Bruckner AL. Section On Dermatology. Atopic dermatitis: skin-directed management. Pediatrics. 2014;134:e1735-1744. doi: 10.1542/peds.2014-2812.
  2. Аллергология. Федеральные клинические рекомендации. Под ред. РМ. Хаитова, Н.И. Ильиной. М.: «Фармарус Принт Медиа»; 2014:69-89.
  3. Намазова-Баранова ЛС, Баранов АА, Кубанова АА, Ильина НИ, Курбачёва ОМ, Вишнёва ЕА и соавт. Атопический дерматит у детей: современные клинические рекомендации по диагностике и терапии. Вопросы современной педиатрии, 2016, т.15, №3, с.279294. doi: 10.15690/vsp.v15i3.1566
  4. Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22:125-137. doi: 10.5021/ad.2010.22.2.125.
  5. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118:152-169. doi: 10.1016/j.jaci.2006.03.045.
  6. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109-1122. doi: 10.1016/S0140-6736(15)00149-X.
  7. Аллергология и иммунология: Национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М.: ГЭОТАР-Медиа; 2009:436-456.
  8. McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131:280-291. doi: 10.1016/j.jaci.2012.12.668.
  9. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131:295-299.e1-27. doi: 10.1016/j.jaci.2012.12.672.
  10. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26:1045-1060. doi: 10.1111/j.1468-3083.2012.04635.x.
  11. Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30:729-747. doi: 10.1111/jdv.13599.
  12. Лусс ЛВ. Коррекция иммунных нарушений при атопическом дерматите у детей. Consilium Medicum. Педиатрия. (Прил.) 2011;(2):40-44.
  13. Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol. 2016;30:223-249. doi: 10.1111/jdv.13301.
  14. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71:1218-1233. doi: 10.1016/j.jaad.2014.08.038.
  15. Sanchez-Borges M, Fernandez-Caldas E, Thomas WR, Chapman MD, Lee BW, Caraballo L et al. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017;10:1-26. doi: 10.1186/s40413-017-0145-4.
  16. Феденко ЕС. Системный подход в лечении атопического дерматита. Лечащий Врач. 2003, №3, с.36-41.
  17. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116-132. doi: 10.1016/j.jaad.2014.03.023.
  18. National Health Service Choices. Emollients. Available at: http://www.nhs.uk/conditions/emollients/Pages/Introduc-tion.aspx Accessed September 3, 2017.
  19. Grillo M, Gassner L, Marshman G, Dunn S, Hudson P. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol. 2006;23:428-436. doi: 10.1111/j.1525-1470.2006.00277.x.
  20. Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332:933-938. doi: 10.1136/bmj.332.7547.933.
  21. Ricci G, Bendandi B, Aiazzi R, Patrizi A, Masi M. Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis. Pediatr Dermatol. 2009;26:1-5. doi: 10.1111/j.1525-1470.2008.00813.x.
  22. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149:582-589. doi: 10.1046/j.1365-2133.2003.05595.x.
  23. Moore E, Williams A, Manias E, Varigos G. Nurse-led clinics reduce severity of childhood atopic eczema: a review of the literature. Br J Dermatol. 2006;155:1242-1248. doi: 10.1111/j.1365-2133.2006.07534.x.
  24. Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol. 2009;50:100-106. doi: 10.1111/j.1440-0960.2009.00515.x.
  25. Niebel G, Kallweit C, Lange I, Folster-Holst R. [Direct versus video-aided parent education in atopic eczema in childhood as a supplement to specialty physician treatment. A controlled pilot study. (In German)]. Hautarzt 2000;51:401-411.
  26. Czarnowicki T, Krueger JG, GuttmanYassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol. 2017;139:17231734. doi: 10.1016/j.jaci.2017.04.004.


Abstract - 6

PDF (Russian) - 0


  • There are currently no refbacks.

Copyright (c) 2017 Russian Allergological Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies